X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5027) 5027
Publication (286) 286
Book Review (27) 27
Newsletter (23) 23
Book Chapter (21) 21
Conference Proceeding (11) 11
Newspaper Article (8) 8
Dissertation (6) 6
Data Set (4) 4
Magazine Article (3) 3
Book / eBook (2) 2
Trade Publication Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2509) 2509
mannitol (2052) 2052
male (2032) 2032
animals (1931) 1931
female (1523) 1523
mannitol - administration & dosage (1508) 1508
index medicus (1465) 1465
mannitol - pharmacology (980) 980
adult (915) 915
middle aged (872) 872
rats (860) 860
pharmacology & pharmacy (706) 706
mannitol - therapeutic use (703) 703
aged (570) 570
time factors (420) 420
permeability (408) 408
surgery (407) 407
dogs (351) 351
osmolar concentration (346) 346
mannitol - chemistry (334) 334
adolescent (327) 327
analysis (306) 306
treatment outcome (299) 299
mannitol - metabolism (261) 261
mice (260) 260
rats, sprague-dawley (249) 249
dose-response relationship, drug (246) 246
clinical neurology (237) 237
particle size (236) 236
administration, inhalation (234) 234
mannitol - adverse effects (231) 231
mannitol - pharmacokinetics (224) 224
research (222) 222
child (221) 221
hypertonic saline (212) 212
neurosciences (209) 209
administration, oral (208) 208
infusions, intravenous (207) 207
immunology (195) 195
intracranial pressure (192) 192
prospective studies (191) 191
respiratory system (191) 191
brain (189) 189
injections, intravenous (189) 189
powders (189) 189
glucose (187) 187
rabbits (182) 182
mannitol - analogs & derivatives (181) 181
care and treatment (175) 175
chemistry, multidisciplinary (173) 173
diuretics, osmotic - administration & dosage (173) 173
physiology (169) 169
rats, wistar (167) 167
drug delivery systems (163) 163
blood-brain barrier - drug effects (161) 161
health aspects (161) 161
absorption (158) 158
intracranial pressure - drug effects (158) 158
in vitro techniques (155) 155
solubility (153) 153
excipients - chemistry (149) 149
medicine, research & experimental (149) 149
blood-brain barrier (146) 146
diuretics, osmotic - therapeutic use (146) 146
research article (144) 144
drugs (143) 143
glucose - pharmacology (142) 142
intestinal permeability (141) 141
kidney - drug effects (141) 141
lactulose (141) 141
medicine & public health (141) 141
young adult (139) 139
retrospective studies (138) 138
glucose - administration & dosage (137) 137
in-vitro (136) 136
hypertonic solutions (135) 135
pressure (135) 135
children (134) 134
critical care medicine (134) 134
physiological aspects (134) 134
article (133) 133
proteins (133) 133
child, preschool (132) 132
gastroenterology & hepatology (132) 132
disease models, animal (131) 131
hydrogen-ion concentration (130) 130
anesthesiology (129) 129
chemistry, pharmaceutical (128) 128
mannitol - urine (127) 127
pharmacy (127) 127
pediatrics (126) 126
perfusion (126) 126
rats, inbred strains (125) 125
intestinal absorption (124) 124
ischemia (124) 124
medicine (123) 123
urology & nephrology (122) 122
transplantation (121) 121
blood pressure - drug effects (120) 120
chemistry, medicinal (120) 120
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4729) 4729
Japanese (140) 140
French (68) 68
German (67) 67
Russian (50) 50
Chinese (45) 45
Italian (29) 29
Spanish (22) 22
Polish (15) 15
Portuguese (7) 7
Romanian (4) 4
Czech (3) 3
Danish (3) 3
Hungarian (3) 3
Korean (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Croatian (1) 1
Finnish (1) 1
Indonesian (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2016, Volume 225, pp. 40 - 52
Journal Article
Aesthetic Plastic Surgery, ISSN 0364-216X, 10/2003, Volume 27, Issue 5, pp. 354 - 366
An increasing number of soft tissue filler substances have been introduced to the beauty market outside the U.S. which lack experimental and clinical data in... 
Dermalive | Evolution | Dermal filler substances | Aquamid | Artecoll | Restylane | Philosophy | New-Fill-Radiance FN | Soft tissue augmentation | Reviderm intra | SURGERY | aquamid | COLLAGEN | MICROSPHERES | PARTICLES | dermal filler substances | evolution | SILICONE | HYALURONIC-ACID GEL | soft tissue augmentation | COSMETIC SURGERY | HYDROXYLAPATITE | New-Fill-radiance FN | IMPLANTATION | LIPODYSTROPHY | COMPLICATIONS | Soft Tissue Infections - etiology | Polymers - administration & dosage | Humans | Granuloma, Foreign-Body - pathology | Silicones - administration & dosage | Cellulose - administration & dosage | Subcutaneous Tissue - surgery | Microspheres | Durapatite - administration & dosage | Carboxymethylcellulose Sodium - administration & dosage | Time Factors | Lactic Acid - administration & dosage | Subcutaneous Tissue - pathology | Hyaluronic Acid - administration & dosage | Methacrylates - administration & dosage | Prostheses and Implants | Materials Testing | Treatment Outcome | Polymethyl Methacrylate - analogs & derivatives | Collagen - administration & dosage | Acrylic Resins - administration & dosage | Hyaluronic Acid - analogs & derivatives | Mannitol - administration & dosage | Polymethyl Methacrylate - administration & dosage | Biocompatible Materials - administration & dosage | Complications and side effects | Collagen | Fillers (Materials) | Product testing | Silicones | Testing
Journal Article
Otology & Neurotology, ISSN 1531-7129, 02/2017, Volume 38, Issue 2, pp. 272 - 277
Journal Article
The Prostate, ISSN 0270-4137, 06/2009, Volume 69, Issue 9, pp. 917 - 927
BACKGROUND A phase I/II trial was conducted to assess feasibility and tolerability of tumor associated antigen peptide vaccination in hormone sensitive... 
peptide vaccination | hormone sensitive | biochemical recurrence | prostate carcinoma | Prostate carcinoma | Biochemical recurrence | Hormone sensitive | Peptide vaccination | DENDRITIC CELLS | CLINICAL-TRIAL | RADICAL PROSTATECTOMY | PERIPHERAL-BLOOD | TUMOR-CELLS | CYTOTOXIC T-LYMPHOCYTES | MESSENGER-RNA | GM-CSF | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | ANTITUMOR IMMUNITY | ANTIGEN | Humans | Middle Aged | Aminoquinolines - administration & dosage | Drug Resistance, Neoplasm | Male | Tomography, X-Ray Computed | Secondary Prevention | Antineoplastic Agents - administration & dosage | Hormones | Prostatic Neoplasms - immunology | Antigens, Neoplasm - administration & dosage | RNA, Messenger - administration & dosage | Hyperthermia, Induced | Protamines - administration & dosage | Antigens, Neoplasm - adverse effects | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | HLA-A2 Antigen - administration & dosage | Cancer Vaccines - administration & dosage | Peptide Fragments - administration & dosage | Cancer Vaccines - adverse effects | Combined Modality Therapy | Prostate-Specific Antigen - blood | HLA-A2 Antigen - adverse effects | Mannitol - analogs & derivatives | Magnetic Resonance Imaging | Mannitol - administration & dosage | Oleic Acids - administration & dosage | Aged | Peptide Fragments - adverse effects | Mucin-1 - genetics | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2003, Volume 21, Issue 21, pp. 4016 - 4026
(Purpose) under bar: To determine clinical and immunologic re sponses to a multipeptide melanoma vaccine regimen, a randomized phase It trial was performed.... 
EPIDERMAL LANGERHANS CELLS | METASTATIC MELANOMA | POTENT | SOLID TUMORS | ONCOLOGY | TYROSINASE | PERIPHERAL-BLOOD | T-CELL | ANTITUMOR IMMUNITY | ANTIGEN | EPITOPES | Melanoma - diagnostic imaging | Dendritic Cells | Skin Neoplasms - drug therapy | Neoplasm Proteins - administration & dosage | Humans | Middle Aged | Male | Thoracic Neoplasms - immunology | Thoracic Neoplasms - diagnostic imaging | gp100 Melanoma Antigen | Interleukin-2 - administration & dosage | Skin Neoplasms - mortality | Adult | Female | Skin Neoplasms - pathology | Skin Neoplasms - diagnostic imaging | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Drug Administration Schedule | Skin Neoplasms - immunology | Cancer Vaccines - administration & dosage | Peptide Fragments - administration & dosage | Treatment Outcome | Lymph Nodes - immunology | Melanoma - secondary | Mannitol - analogs & derivatives | Radiography | Membrane Glycoproteins - administration & dosage | Monophenol Monooxygenase - administration & dosage | Thoracic Neoplasms - mortality | Thoracic Neoplasms - secondary | Melanoma - immunology | Mannitol - administration & dosage | Melanoma - drug therapy | Oleic Acids - administration & dosage | Survival Analysis | T-Lymphocytes - immunology | Aged | Thoracic Neoplasms - drug therapy | Melanoma - mortality
Journal Article
Journal Article
The Neurologist, ISSN 1074-7931, 11/2019, Volume 24, Issue 6, pp. 176 - 179
BACKGROUND:Central venous catheters are often used to administer hypertonic saline (HTS) but might be associated with serious complications. Intraosseous (IO)... 
RANDOMIZED CONTROLLED-TRIALS | PAIN OBSERVATION TOOL | SWINE | ADULTS | INFUSION | MANNITOL | intraosseous access | CLINICAL NEUROLOGY | SALT | PROXIMAL HUMERUS | hypertonic saline | SODIUM SOLUTIONS | vascular access | osmotherapy | RESUSCITATION
Journal Article
The Journal of Immunology, ISSN 0022-1767, 03/2005, Volume 174, Issue 5, pp. 3080 - 3086
Twelve peptides derived from melanocyte differentiation proteins and cancer-testis Ags were combined and administered in a single mixture to patients with... 
Adjuvants, Immunologic - administration & dosage | Neoplasm Proteins - administration & dosage | Humans | Membrane Glycoproteins - biosynthesis | Neoplasm Proteins - immunology | Molecular Sequence Data | Antineoplastic Agents - administration & dosage | Vaccines, Combined - administration & dosage | gp100 Melanoma Antigen | Peptide Fragments - immunology | CD8-Positive T-Lymphocytes - metabolism | Cytotoxicity Tests, Immunologic - methods | Membrane Glycoproteins - immunology | Amino Acid Sequence | Melanoma-Specific Antigens | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Peptide Fragments - metabolism | Antigens, Neoplasm | Neoplasm Proteins - biosynthesis | Cancer Vaccines - administration & dosage | Peptide Fragments - administration & dosage | Lymph Nodes - metabolism | Vaccines, Subunit - immunology | Lymph Nodes - immunology | Melanoma - pathology | Protein Binding - immunology | Mannitol - analogs & derivatives | Cancer Vaccines - immunology | Membrane Glycoproteins - administration & dosage | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Melanoma - immunology | Vaccines, Subunit - administration & dosage | Mannitol - administration & dosage | Oleic Acids - administration & dosage | Cell Line, Tumor | Mannitol - immunology | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Oleic Acids - immunology | Cell Line, Transformed
Journal Article
Transplantation Proceedings, ISSN 0041-1345, 2012, Volume 44, Issue 8, pp. 2326 - 2332
Journal Article
Transplantation Proceedings, ISSN 0041-1345, 03/2018, Volume 50, Issue 2, pp. 539 - 542
Journal Article